Medtronic apps compatibility search tool
Check compatibility for EMEA region (Europe, Middle East and Africa). Notice that compatibility may vary depending on the country
MiniMed™ Mobile App
You will be able to display key insulin pump data right on your smartphone. Discover a new way to interact with your MiniMed™ insulin pump and continuous glucose monitoring (CGM) data.
CareLink™ Connect App
For care partners. An easy way to remotely view the glucose levels and insulin pump information of a person with diabetes.
InPen™ App
The InPen™ System includes the InPen™ smart insulin pen and the InPen™ app. The InPen™ System automatically records dose size and timing of insulin doses, provides reminders if insulin is not taken, includes an insulin dose calculator with personalized settings, tracks insulin on board, and has the ability to integrate with other diabetes technologies, including a continuous glucose monitoring (CGM). For more information, refer to Help section of the app.
Guardian™ app
The Guardian™ application (app) is a component of the Guardian 4 system that helps manage diabetes. The Guardian™ 4 system has the following features:
- Records glucose values throughout the day and night
- Displays glucose values in a convenient and discreet manner on a mobile device
- Sends alerts for glucose events on a mobile device
- Shows the effects that diet, exercise, and insulin can have on glucose levels
Simplera™ app
The Simplera™ sensor aims to further reduce the burden of diabetes for those on multiple daily injections (MDI) therapy by offering an all-in-one disposable sensor connected to the Simplera™ app for real-time SG readings and predictive alerts.
Frequently asked questions
Samsung, Xiaomi, Google, LG, Motorola, Huawei One Plus, Sony
Go to Settings > General > About > Model name.
Apple device
Go to Settings > General > About > Model name.
The warning message is there to indicate that the current system has not yet been fully tested or supported. While we cannot guarantee full app functionality until the release has been fully tested, clicking out of the warning message will enable the app to work. The warning message will not appear once we have fully tested the new app version. In the meantime, if you do experience any issues, our Product Support team will be happy to help troubleshoot to the best of our ability.
We recommend that you check your devices & OS compatibility before updating your operating system. If it is not listed as compatible, we recommend not updating your operating system until we have tested and ensured full compatibility.
We are working with Apple and Android to test beta versions as soon as they become available, in order to ensure full compatibility as soon as possible. However, if we discover the new operating system has caused a change to the intended behavior of the app, then it may take additional time to ensure that the app fully functions as intended with the new operating system.
If we have not validated the manufacturer of the device or the device is on an unsupported operating system, then the devices is not compatible and will not be available for download from the Google Play Store or App Store and will not work on your device.
If your device or operating system is an unverified device then you will receive an in-app pop-up message the first time you log into the app informing you that your app can still be used but it has not been tested. As a result, some information could display differently than intended and we recommend that you use the app with a fully-tested device. However, if you do experience any issues with your device, our Product Support team will be happy to help troubleshoot to the best of our ability.
We are sorry to hear that you are experiencing an issue! Your device has not been fully tested with the app and as such we are unable to guarantee the performance of the device. However, we will be happy to help troubleshoot to the best of our ability - Please contact our Product Support team.
On your Android device, visit Google Play Store. If the InPen™ app is visible in the Play Store, install it. If the InPen™ app is not visible in the Play Store, the device does not meet minimum requirements to install the app. Once app is installed, Open the InPen™ App. Upon opening the app, it will check to make sure the screen resolution meets minimum requirements. If you are presented with a login screen, the app is ready for use.
The Guardian™ app and the InPen™ app have a different approach to compatibility and use different technology protocols, therefore compatibility is different between the two mobile apps.
Important safety information
The MiniMed™ Mobile app is intended to provide a secondary display for a compatible MiniMed™ insulin pump system on a suitable consumer electronic device for passive monitoring and to sync data to CareLink™ system. The MiniMed™ Mobile app is not intended to replace the real-time display of continuous glucose monitoring or insulin pump data on the primary display device (i.e., the insulin pump). All therapy decisions should be based on the primary display device.
The MiniMed™ Mobile app is not intended to analyze or modify the continuous glucose monitoring data or insulin pump data that it receives. Nor is it intended to control any function of the connected continuous glucose monitoring system or insulin pump. The MiniMed™ Mobile app is not intended to receive information directly from the sensor or transmitter of a continuous glucose monitoring system.
The CareLink™ Connect app is intended to provide a secondary display of insulin pump and CGM (Continuous Glucose Monitor) data on a supported mobile device. CareLink™ Connect app is not intended to replace the real-time display of insulin pump or CGM data on the primary display device. All therapy decisions should be based on the primary display device.
CareLink™ Connect app is not intended to analyze or modify the insulin pump and CGM data that it receives. Nor is it intended to control any function of the insulin pump or CGM system to which it is connected. CareLink™ Connect app is not intended to receive information directly from the insulin pump or CGM system.
For complete product and safety information, see the user guide.
The InPen™ is intended for single-patient use by people with diabetes for the self-injection of a desired dose of insulin. The pen injector is compatible with 3.0 mL cartridges of insulin (U-100) and single-use detachable and disposable pen needles (not included). The pen injector allows the user to dial the desired dose from 0.5 to 30 units in one-half (1/2) unit increments.
The InPen™ System is contraindicated in patients who fail to meet all criteria as determined by the labeling of the drug or medicine to be administered.
The Guardian™ app is intended to be used with the Guardian™ 4 system.The Guardian™ 4 system is a real-time, CGM system indicated for the management of diabetes in persons age 7 years and older.The Guardian™ 4 system does not require calibration and is designed to replace finger stick BG testing for diabetes treatment decisions. Treatment decisions should be made based on the combination of SG readings and trend arrows. The system can track trends in glucose concentrations, and aid in detecting events of hyperglycemia and hypoglycemia and helping both current and long-term therapy decisions.
The system is intended for use only by patients and caregivers using a compatible mobile device and operating system, and who have sufficient experience to adjust mobile device audio and notification settings. The system may require a prescription.
Successful CGM use requires sufficient vision or hearing ability to allow recognition of the alerts generated by the Guardian app.
The Simplera™ app is intended to be used with the Simplera™ system. The Simplera™ system is a real-time, CGM system indicated for the management of diabetes in persons age 2 years and older.
The Simplera™ system is designed to replace fingerstick BG testing for diabetes treatment decisions. Treatment decisions should be made based on the combination of SG readings and trend arrows. The system can track trends in glucose concentrations, and aid in detecting events of hyperglycemia and hypoglycemia and helping both current and long-term therapy decisions.
The system is intended for use only by patients and caregivers using a compatible mobile device and operating system, and who have sufficient experience to adjust mobile device audio and notification settings. The system may require a prescription.
Information contained herein is not medical advice and should not be used as an alternative to speaking with your doctor. Discuss indications, contraindications, warnings, precautions, potential adverse events and any further information with your health care professional.